Walleye Trading
LUMO

Walleye Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Walleye Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,639
Closed -$272K – 5442
2018
Q3 		$272K Buy
12,639
+9,175
+265% +$279K ﹤0.01% 3488
2018
Q2 		$148K Buy
+3,464
New +$159K ﹤0.01% 3831

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's LUMO Position: Q4 2018 in Review

Walleye Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018, closing a stake of 12,639 shares — an estimated $272K sold.

Walleye Trading first reported a position in LUMO in Q2 2018 and held it in 2 quarters. The position peaked at $272K in Q3 2018. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

  • Walleye Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 12,639 Lumos Pharma, Inc. Common Stock shares in Q4 2018, an estimated $272K.
  • Walleye Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Walleye Trading's Lumos Pharma, Inc. Common Stock position peaked at $272K in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.